These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 7319911

  • 1. Biosynthesis of aklavinone and aclacinomycins.
    Kitamura I, Tobe H, Yoshimoto A, Oki T, Naganawa H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1981 Nov; 34(11):1498-500. PubMed ID: 7319911
    [No Abstract] [Full Text] [Related]

  • 2. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
    Oki T, Yoshimoto A, Matsuzawa Y, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
    [Abstract] [Full Text] [Related]

  • 3. Modification of aklavinone and aclacinomycins in vitro and in vivo by rhodomycin biosynthesis gene products.
    Wang Y, Niemi J, Mäntsälä P.
    FEMS Microbiol Lett; 2002 Feb 19; 208(1):117-22. PubMed ID: 11934504
    [Abstract] [Full Text] [Related]

  • 4. Isolation and characterization of aclacinomycin A-non-producing Streptomyces galilaeus (ATCC 31615) mutants.
    Ylihonko K, Hakala J, Niemi J, Lundell J, Mäntsälä P.
    Microbiology (Reading); 1994 Jun 19; 140 ( Pt 6)():1359-65. PubMed ID: 8081501
    [Abstract] [Full Text] [Related]

  • 5. Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A.
    Hoshino T, Sekine Y, Fujiwara A.
    J Antibiot (Tokyo); 1983 Nov 19; 36(11):1458-62. PubMed ID: 6581152
    [Abstract] [Full Text] [Related]

  • 6. Cloning and characterization of Streptomyces galilaeus aclacinomycins polyketide synthase (PKS) cluster.
    Räty K, Kantola J, Hautala A, Hakala J, Ylihonko K, Mäntsälä P.
    Gene; 2002 Jun 26; 293(1-2):115-22. PubMed ID: 12137949
    [Abstract] [Full Text] [Related]

  • 7. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants.
    Yoshimoto A, Matsuzawa Y, Oki T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1981 Aug 26; 34(8):951-8. PubMed ID: 6947976
    [Abstract] [Full Text] [Related]

  • 8. Compartmentation of enzymes interconverting aclacinomycins in Streptomyces species AM 33352.
    Gräfe U, Dornberger K, Fleck WF, Freysoldt C.
    J Basic Microbiol; 1988 Aug 26; 28(1-2):17-23. PubMed ID: 3171922
    [Abstract] [Full Text] [Related]

  • 9. Biosynthesis of daunomycinone from aklavinone and epsilon-rhodomycinone.
    Yoshimoto A, Oki T, Umezawa H.
    J Antibiot (Tokyo); 1980 Oct 26; 33(10):1199-201. PubMed ID: 7451370
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Formation of the anthracycline antibiotics, beromycin and nogalamycin, by a new actinomycete species, Streptomyces glomeratus sp. nov].
    Gauze GF, Brazhnikova MG, Borisova VN, Maksimova TS, Ol'khovatova OL.
    Antibiotiki; 1978 Jun 26; 23(6):483-9. PubMed ID: 677831
    [Abstract] [Full Text] [Related]

  • 13. Microbial transformation of aklanonic acid, a potential early intermediate in the biosynthesis of anthracyclines.
    Wagner C, Eckardt K, Schumann G, Ihn W, Tresselt D.
    J Antibiot (Tokyo); 1984 Jun 26; 37(6):691-2. PubMed ID: 6430856
    [No Abstract] [Full Text] [Related]

  • 14. Effect of aeration efficiency and carbon source on the production of anthracyclines in Streptomyces galilaeus.
    Královcová E, Vanĕk Z.
    Folia Microbiol (Praha); 1979 Jun 26; 24(4):301-7. PubMed ID: 527905
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin.
    Hwang CK, Kim HS, Hong YS, Kim YH, Hong SK, Kim SJ, Lee JJ.
    Antimicrob Agents Chemother; 1995 Jul 26; 39(7):1616-20. PubMed ID: 7492117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Engineering anthracycline biosynthesis toward angucyclines.
    Metsä-Ketelä M, Palmu K, Kunnari T, Ylihonko K, Mäntsälä P.
    Antimicrob Agents Chemother; 2003 Apr 26; 47(4):1291-6. PubMed ID: 12654660
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant.
    Johdo O, Yoshioka T, Naganawa H, Takeuchi T, Yoshimoto A.
    J Antibiot (Tokyo); 1996 Jul 26; 49(7):669-75. PubMed ID: 8784429
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.